Fig. 3

Small molecular compounds reducing viral infection. a LTR-driven EGFP expression was reduced by more than −0.5 log₂ fold change by 16 compounds compared to no drug control (ns not significant, *p < 0.05, **p < 0.01, ***p < 0.001). b Table listing the 16 compounds reducing HIV infection with target proteins, percent infection, and viability data